Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 30, 2025 • 11:00 AM ET

Date/Time Source News Release
09/21/2021 12:47 PM EDT GlobeNewswire AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today
09/14/2021 07:30 AM EDT GlobeNewswire AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
09/13/2021 06:00 AM EDT GlobeNewswire AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
09/10/2021 12:45 PM EDT GlobeNewswire AzurRx BioPharma Announces Reverse Stock Split
09/10/2021 08:30 AM EDT GlobeNewswire AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
09/09/2021 08:30 AM EDT GlobeNewswire AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
09/08/2021 08:30 AM EDT GlobeNewswire AzurRx BioPharma Submits an Investigational New Drug Application for Niclosamide as Treatment for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-Associated Colitis
09/07/2021 04:30 PM EDT GlobeNewswire AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
08/18/2021 07:05 AM EDT GlobeNewswire AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)
08/17/2021 07:00 AM EDT GlobeNewswire AzurRx BioPharma Announces WHO Publication of "Adrulipase Alfa" as International Nonproprietary Name for MS1819
Page

Additional News

As of March 30, 2025 • 11:00 AM ET

Date/Time Source News Release
09/15/2021 09:20 AM EDT PennyStocks.com 3 Penny Stocks That Top Investors Buying Right Now
09/14/2021 11:35 AM EDT Zacks AzurRx (AZRX) Announces First Wave Bio Acquisition for $229M
09/14/2021 08:22 AM EDT SeekingAlpha NNVC, LIFE and DATS pre market gainers
09/13/2021 04:40 PM EDT SeekingAlpha AzurRx BioPharma, Inc. (AZRX) CEO James Sapirstein on First Wave Bio Acquisition - Conference Call Transcript
08/25/2021 10:04 AM EDT PennyStocks.com 3 Penny Stocks That Top Investors Are Buying Right Now
08/18/2021 01:34 PM EDT InvestorPlace AZRX Stock: The Huge Trial News Lifting Little-Known AzurRX BioPharma Today
08/18/2021 12:43 PM EDT SeekingAlpha SLI, XAIR, MBII among mid-day movers
07/26/2021 12:37 PM EDT PennyStocks.com Biotech Penny Stocks Are Heating Up, Here's 3 To Watch Right Now
07/26/2021 07:28 AM EDT InvestorPlace Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
07/19/2021 12:07 PM EDT InvestorBrandNetwork Watch for Continued Losses in Shares of AzurRx BioPharma Inc. (AZRX)
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.